The results show that MUC6 inhibited tumor aggression via autophagy- dependent β-catenin degradation and MUC6 mutations compromised autophagy- dependent β-catenin degradation as well as the tumor-suppressive effects of MUC6. The gene discussed is MUC6; the disease is neoplasm.